Strateos is a pioneer in the development of remote access laboratories and lab control software for the life sciences. Founded in 2012 and headquartered in the United States, the company's mission is to create new knowledge driven by data, computation, automation, and high-throughput robotics to advance the life sciences. The Strateos Automation-as-a-Service Platform aims to help scientists efficiently design, run, and analyze experiments for faster scientific discoveries in the fields of biotechnology, information technology, and robotics.
The company has recently secured a significant $56.10M Series B investment on 08 June 2021. This funding round saw participation from notable investors including Lux Capital, BDV Fund, Dolby Ventures, Ally Bridge Group, Alumni Ventures Blockchain Fund, Harmonix Fund, AME, StreShi, Mack-Cali Realty Corporation, and Castor Ventures.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $56.10M | 10 | Mack-Cali Realty Corporation, Castor Ventures | 08 Jun 2021 |
Series B | $4.00M | 1 | 31 Dec 2020 | |
Series B | $1.40M | 1 | 11 Dec 2020 | |
Venture Round | $16.50M | 4 | 26 Jul 2019 | |
Venture Round | Unknown | - | 12 Dec 2018 |
No recent news or press coverage available for Strateos.